Organizer
Waters Corporation
Waters Corporation
Waters Corporation, the world's leading specialty measurement company, has pioneered chromatography, mass spectrometry and thermal analysis innovations serving the life, materials and food sciences for nearly 60 years.
Tags
GPC/SEC
LinkedIn Logo

Is your Biosimilar, Similar?

Th, 28.5.2026 16:00 CEST
Explore regulatory expectations and advanced SEC-MALS workflows for biosimilarity assessment of monoclonal antibodies, including CQAs, aggregation analysis, and impurity profiling.
Go to the webinar
Waters Corporation: Upcoming events
Waters Corporation: Upcoming events

In this live webinar, Rakesh (USP) and Bretton (Waters) bring together regulatory insight and practical analytical expertise to explore strategies to assess critical quality attributes (CQAs).

Rakesh will focus on the analysis of comparative analytical assessment studies from successful regulatory filings of mAb biosimilars in the U.S. and EU, which identified the most common CQAs and analytical methods included in comparative studies and highlight increased adoption of more specific and efficient "analytical methods."

Biosimilarity assessment requires an extensive set of analytical tools that directly address the biophysical characterization parameters emphasized in the latest U.S. FDA biosimilar guidance and ICH Q6B . Size exclusion chromatography combined with multi-angle light scattering (SEC-MALS) has emerged as a critical technique for defining molecular weight, aggregation, impurity profiles, and related quality characteristics that support regulatory decision-making processes.

Bretton will explain how SEC-MALS can be used to measure these characteristics for biosimilars and other biological modalities.

Presenter: Rakesh Aithal, Ph.D. (Team Lead, Senior Scientist I, Pipeline Development, Global Biologics, United States Pharmacopeia)

Rakesh Aithal is currently working as a Team Lead, Senior Scientist I in the Pipeline Development Team of Global Biologics at USP. In this role, he works closely with scientific experts and stakeholders to develop physical and documentary standards used to support development and quality assessment of biopharmaceuticals with a major focus on protein therapeutics including monoclonal antibodies and antibody conjugates. He did his Ph.D. in Biomolecular Chemistry from Masaryk University and worked as a post-doctoral researcher in Cancer Research Center Marseille on the mechanistic understanding of meiotic recombination before transitioning into the biopharmaceutical industry. He has extensive expertise in a range of analytical methods for protein characterization and molecular biology techniques; and has published several research articles in peer reviewed journals. His expertise includes analytical method development, qualification, and validation along with comparative analytical similarity assessments to support biosimilar development.

Presenter: Bretton Fletcher, Ph.D. (Scientist, Waters | Wyatt Technology)

Bretton Fletcher, Ph.D. is an application scientist in the Analytical Sciences team at Waters | Wyatt Technology. He assists customers in identifying the best light scattering solutions for their analytical needs by leveraging her expertise in multi-angle light scattering. He performs feasibility studies to characterize customer samples and participates in Wyatt’s Light Scattering University. He completed his Ph.D. in Biomolecular Sciences and Engineering from the University of California, Santa Barbara.

Moderated by: Samuel Seal (Biopharma Market Development Manager, Waters Corporation)

Samuel Seal is a market development manager specializing in the biologics space. He loves LC and MS – especially on how this technology provides benefit and value.

Sam joined Waters in January of 2014 as a Sales Technical Support Specialist in the Irvine office/lab. As a TSS he performed demonstrations on various instruments, provided training for customers, often presented on technical information at varying events, and assisted with troubleshooting from Colorado to Los Angeles.

He previously worked at Pyxant Labs in Colorado Springs, CO where he gained extensive experience developing and validating methods for small/large molecules in bioanalytical assays, agricultural commodities, registration of pesticides, and worker exposure studies. He also has experience in column chromatography, sample extraction, sample clean-up, reporting and data management. Sam has hands on experience with running and maintaining various manufacturers' LC/MS/MS systems. Prior to Pyxant, Sam was a Laboratory Instructor at the University of Colorado at Colorado Springs where he earned his Bachelor of Arts in Biology and Bachelor of Arts in Chemistry.

Waters Corporation
LinkedIn Logo
 

Related content

Comprehensive and Robust Analysis of Ultrashort- to Long-Chain PFAS, PAE, OPE, and PAH

Applications
| 2026 | Agilent Technologies
Instrumentation
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Manufacturer
Agilent Technologies, Plasmion
Industries
Environmental

UPLC™ Separation of Fifteen Bisphenols Using a Waters Acquity™ Biphenyl RP Column with MaxPeak™ Premier Technology and UV Detection

Applications
| 2026 | Waters
Instrumentation
Consumables, LC columns, HPLC
Manufacturer
Waters
Industries
Pharma & Biopharma

Achieving Low‑ppb Bisphenol Quantitation with the Agilent InfinityLab Pro iQ Mass Detector

Applications
| 2026 | Agilent Technologies
Instrumentation
LC/MS, LC/SQ
Manufacturer
Agilent Technologies
Industries
Materials Testing

ECL detection of fentanyl

Applications
| 2026 | Metrohm
Instrumentation
Electrochemistry
Manufacturer
Metrohm
Industries
Forensics

Early-stage drug metabolite quantitation without radiolabels

Applications
| 2026 | Thermo Fisher Scientific
Instrumentation
HPLC, LC/MS, LC/SQ
Manufacturer
Thermo Fisher Scientific
Industries
Pharma & Biopharma, Metabolomics
Other projects
GCMS
ICPMS
Follow us
FacebookX (Twitter)LinkedInYouTube
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike